共 98 条
[1]
Kojima G(2017)Prevalence of frailty in Japan: A systematic review and meta-analysis J Epidemiol 27 347-353
[2]
Iliffe S(2001)Frailty in older adults: evidence for a phenotype J Gerontol A Biol Sci Med Sci 56 146-156
[3]
Taniguchi Y(2019)The prevalence of sarcopenia in community-dwelling older adults, an exploration of differences between studies and within definitions: a systematic review and meta-analyses Age Ageing 48 48-56
[4]
Shimada H(2021)Sarcopenia: prevalence, associated factors, and the risk of mortality and disability in Japanese older adults J Cachexia Sarcopenia Muscle 12 30-38
[5]
Rakugi H(2017)Sarcopenia Is Associated With Physical and Mental Components of Health-Related Quality of Life in Older Adults J Am Med Dir Assoc 18 636 e631-636 e635
[6]
Walters K(2022)Sarcopenia reduces quality of life in the long-term: longitudinal analyses from the English longitudinal study of ageing Eur Geriatr Med 13 633-639
[7]
Fried LP(2004)The healthcare costs of sarcopenia in the United States J Am Geriatr Soc 52 80-85
[8]
Tangen CM(2016)Financial impact of sarcopenia on hospitalization costs Eur J Clin Nutr 70 1046-1051
[9]
Walston J(2013)GFR estimation using standardized serum cystatin C in Japan Am J Kidney Dis 61 197-203
[10]
Mayhew AJ(2019)Serum creatinine and cystatin C-based index can be a screening biomarker for sarcopenia in older population Eur Geriatr Med 10 625-630